365 related articles for article (PubMed ID: 23784006)
21. Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules.
Nunès JA; Truneh A; Olive D; Cantrell DA
J Biol Chem; 1996 Jan; 271(3):1591-8. PubMed ID: 8576157
[TBL] [Abstract][Full Text] [Related]
22. Immunomodulatory drug costimulates T cells via the B7-CD28 pathway.
LeBlanc R; Hideshima T; Catley LP; Shringarpure R; Burger R; Mitsiades N; Mitsiades C; Cheema P; Chauhan D; Richardson PG; Anderson KC; Munshi NC
Blood; 2004 Mar; 103(5):1787-90. PubMed ID: 14512311
[TBL] [Abstract][Full Text] [Related]
23. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.
Linsley PS; Brady W; Grosmaire L; Aruffo A; Damle NK; Ledbetter JA
J Exp Med; 1991 Mar; 173(3):721-30. PubMed ID: 1847722
[TBL] [Abstract][Full Text] [Related]
24. Expression and functional significance of an additional ligand for CTLA-4.
Lenschow DJ; Su GH; Zuckerman LA; Nabavi N; Jellis CL; Gray GS; Miller J; Bluestone JA
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11054-8. PubMed ID: 7504292
[TBL] [Abstract][Full Text] [Related]
25. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
[TBL] [Abstract][Full Text] [Related]
26. CD28/B7 costimulation: a review.
Greenfield EA; Nguyen KA; Kuchroo VK
Crit Rev Immunol; 1998; 18(5):389-418. PubMed ID: 9784967
[TBL] [Abstract][Full Text] [Related]
27. Immunosuppression through blockade of CD28:B7-mediated costimulatory signals.
Judge TA; Tang A; Turka LA
Immunol Res; 1996; 15(1):38-49. PubMed ID: 8739564
[TBL] [Abstract][Full Text] [Related]
28. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
Koulova L; Clark EA; Shu G; Dupont B
J Exp Med; 1991 Mar; 173(3):759-62. PubMed ID: 1847724
[TBL] [Abstract][Full Text] [Related]
29. Absence of B7-dependent responses in CD28-deficient mice.
Green JM; Noel PJ; Sperling AI; Walunas TL; Gray GS; Bluestone JA; Thompson CB
Immunity; 1994 Sep; 1(6):501-8. PubMed ID: 7534617
[TBL] [Abstract][Full Text] [Related]
30. CD28-independent costimulation of T cells in alloimmune responses.
Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
[TBL] [Abstract][Full Text] [Related]
31. CD28: a signalling perspective.
Ward SG
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):361-77. PubMed ID: 8809021
[TBL] [Abstract][Full Text] [Related]
32. B7-H7 Is Inducible on T Cells to Regulate Their Immune Response and Serves as a Marker for Exhaustion.
Luu K; Schwarz H; Lundqvist A
Front Immunol; 2021; 12():682627. PubMed ID: 34140952
[TBL] [Abstract][Full Text] [Related]
33. Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells.
Gause WC; Urban JF; Linsley P; Lu P
Immunol Res; 1995; 14(3):176-88. PubMed ID: 8778208
[TBL] [Abstract][Full Text] [Related]
34. Intact B7-H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses.
Ueno T; Yeung MY; McGrath M; Yang S; Zaman N; Snawder B; Padera RF; Magee CN; Gorbatov R; Hashiguchi M; Azuma M; Freeman GJ; Sayegh MH; Najafian N
Eur J Immunol; 2012 Sep; 42(9):2343-53. PubMed ID: 22733595
[TBL] [Abstract][Full Text] [Related]
35. Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation.
de Boer OJ; Hirsch F; van der Wal AC; van der Loos CM; Das PK; Becker AE
Atherosclerosis; 1997 Sep; 133(2):227-34. PubMed ID: 9298683
[TBL] [Abstract][Full Text] [Related]
36. Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phase.
Li XL; Sluijter M; Doorduijn EM; Kale SP; McFerrin H; Liu YY; Li Y; Mottamal M; Yao X; Du F; Gu B; Hoang K; Nguyen YH; Taylor N; Stephens CR; van Hall T; Zhang QJ
PLoS One; 2014; 9(11):e108192. PubMed ID: 25383875
[TBL] [Abstract][Full Text] [Related]
37. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J
J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647
[TBL] [Abstract][Full Text] [Related]
38. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4.
Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
J Immunol; 2001 Mar; 166(5):3107-13. PubMed ID: 11207262
[TBL] [Abstract][Full Text] [Related]
39. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production.
Soos JM; Ashley TA; Morrow J; Patarroyo JC; Szente BE; Zamvil SS
Int Immunol; 1999 Jul; 11(7):1169-79. PubMed ID: 10383950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]